Cyclobenzaprine - ALZA Corporation

Drug Profile

Cyclobenzaprine - ALZA Corporation

Alternative Names: Flexeril; Flexeril XL; MK-130; OROS Cyclobenzaprine

Latest Information Update: 02 Aug 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ALZA Corporation
  • Class Dibenzocycloheptenes; Muscle relaxants; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Musculoskeletal pain; Spasm

Most Recent Events

  • 30 Jul 2010 Generic equivalent available in USA for Spasm
  • 30 Oct 2003 Data from a media release have been added to the adverse events and Musculoskeletal Disorders therapeutic trials sections
  • 25 Jun 2003 Data from a media release have been added to the Musculoskeletal pain therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top